Enbridge reports record Q2 2025 earnings, driven by strong liquids flows, growing power demand, and higher natural gas transmission and midstream operations.
Regeneron beats Q2 earnings estimates on strong Dupixent sales, despite challenges with Eylea and regulatory delays.
16 states sue Trump administration over crackdown on transgender youth healthcare
Enbridge reports record Q2 2025 earnings, driven by strong liquids flows, growing power demand, and higher natural gas transmission and midstream operations.
Regeneron beats Q2 earnings estimates on strong Dupixent sales, despite challenges with Eylea and regulatory delays.
16 states sue Trump administration over crackdown on transgender youth healthcare